Skip to content

The Analgesic Efficacy of Protocol for Primary Total Knee Arthroplasty (TKA)

The Analgesic Efficacy of Adding the IPACK Block to a Multimodal Analgesia Protocol for Primary Total Knee Arthroplasty

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03703206
Enrollment
120
Registered
2018-10-11
Start date
2018-07-01
Completion date
2021-08-27
Last updated
2024-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Arthroplasty, Total

Brief summary

This is a perspective, randomized, blinded study with a parallel design and an allocation ratio of 1 to 1 for the treatment groups to assess the analgesic efficacy of adding the iPACK (injection between the popliteal artery and the capsule of the knee) in addition to the adductor canal block (ACB) for Total Knee Arthoplasty patients (TKA).

Interventions

DRUGultrasound guided injection of local anesthetic between the popliteal artery and the capsule of the knee (iPACK)

nerve block for posterior knee pain after a TKA.

Sponsors

University of Pennsylvania
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Intervention model description

This is a prospective, randomized, blinded study with a parallel design and an allocation ratio of 1 to 1 for the treatment groups

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Patients scheduled for total knee arthroplasty * American Society Anesthesiologists (ASA) physical status I- III. * Mentally competent and able to give consent for enrollment in the study.

Exclusion criteria

* Patient refusal, * allergy to local anesthetics, systemic opioids (fentanyl, morphine, hydromorphone, and any of the drugs included in the multimodal perioperative pain protocol (MP3). * Revision surgery will be excluded. * Impaired kidney functions * patient with coagulopathy will be also excluded. * Chronic pain syndromes and patients with chronic opioid use in excess of a daily morphine equivalent dose (MED) of 40mg or greater for the past 3 months prior to the surgery. * BMI of 45 or more

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Patients Presenting With Pain in the Back of the Knee 6 Hours After SurgerySix hours after surgeryEach patient will be provided by a colored chart that will have different parts of the knee marked clearly and they will indicate whether the pain they have in which region of the knee. the different regions are ( anterior, posterior, lateral, medial, and the middle of the thigh). it will be marked as a yes or no question. it will be measured as a ratio of patients in each patient who has the pain in the numerator and all patients in the study will be in the denominator

Secondary

MeasureTime frameDescription
Pain Score Measurement Reported by Patients24 hours after surgeryAverage of pain scores over the first 24 hours following the regional anesthetic based on Numeric Rating Scale ( NRS). The scale is from 0 - 10, where 0 is no pain and 10 is the worst pain possible.
Quality of Recovery (QoR) Scoreone week, measurements are obtained at 24 hours, 48 hours, and one weekScore of QoR-15 survey to determine recovery status. The questionnaire is a 15 item questionnaire and each question has a score possible from 0-10. It has two parts. Part 1 includes questions from 1-10. the scale on this question ranges from 0=none of the time ( poor) to 10=all the time ( excellent). The 2nd part include questions from 11-15 where the scale goes from 10 to 0, where 10=none of the time ( excellent) and 0=all the time (poor). The total score is obtained by adding the scores of all the 15 questions. The total score is 0 (poor\_ to 150 (excellent).

Countries

United States

Participant flow

Recruitment details

Four hundred and sixty-four patients were screened for eligibility, with 120 patients ultimately enrolling in the study. Of the 120 patients enrolled, 119 patients completed all necessary follow-up for inclusion into the study

Pre-assignment details

120 patients enrolled, 119 patients completed all necessary follow-up for inclusion in the study: 60 patients in the IPACK group and 59 patients in the sham group. There were no block failures. These 119 patients were randomized to receive either an IPACK or a sham block in addition to multimodal analgesia and an ACB. We were set to assess pain in the back of the knee 6 hours after surgery, quality of recovery after surgery, pain scores, opioid requirements, and functional measures

Participants by arm

ArmCount
ACB + iPACK
Patients scheduled for TKA will be randomized to receive an adductor canal block with an additional ultrasound guided injection of local anesthetic between the popliteal artery and the capsule of the knee (iPACK). Ultrasound guided injection of local anesthetic between the popliteal artery and the capsule of the knee (iPACK): nerve block for posterior knee pain after a TKA.
60
ACB w/o iPACK
Patients enrolled in this arm will receive the standard of care adductor canal block (ACB) prior to their total knee arthoplasty.
59
Total119

Baseline characteristics

CharacteristicACB + iPACKACB w/o iPACKTotal
Age, Continuous67.7 Age (years)
STANDARD_DEVIATION 7.8
65.6 Age (years)
STANDARD_DEVIATION 8.2
66.7 Age (years)
STANDARD_DEVIATION 8.03
Race/Ethnicity, Customized
African American
14 Participants20 Participants34 Participants
Race/Ethnicity, Customized
Other
1 Participants1 Participants2 Participants
Race/Ethnicity, Customized
White
45 Participants38 Participants83 Participants
Sex: Female, Male
Female
34 Participants35 Participants69 Participants
Sex: Female, Male
Male
26 Participants24 Participants50 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 600 / 59
other
Total, other adverse events
0 / 600 / 59
serious
Total, serious adverse events
0 / 600 / 59

Outcome results

Primary

Percentage of Patients Presenting With Pain in the Back of the Knee 6 Hours After Surgery

Each patient will be provided by a colored chart that will have different parts of the knee marked clearly and they will indicate whether the pain they have in which region of the knee. the different regions are ( anterior, posterior, lateral, medial, and the middle of the thigh). it will be marked as a yes or no question. it will be measured as a ratio of patients in each patient who has the pain in the numerator and all patients in the study will be in the denominator

Time frame: Six hours after surgery

ArmMeasureValue (NUMBER)
ACB + iPACKPercentage of Patients Presenting With Pain in the Back of the Knee 6 Hours After Surgery21.7 percentage of patients reporting pain
ACB w/o iPACKPercentage of Patients Presenting With Pain in the Back of the Knee 6 Hours After Surgery45.8 percentage of patients reporting pain
Secondary

Pain Score Measurement Reported by Patients

Average of pain scores over the first 24 hours following the regional anesthetic based on Numeric Rating Scale ( NRS). The scale is from 0 - 10, where 0 is no pain and 10 is the worst pain possible.

Time frame: 24 hours after surgery

ArmMeasureValue (MEAN)Dispersion
ACB + iPACKPain Score Measurement Reported by Patients5 pain scoresStandard Deviation 0.01
ACB w/o iPACKPain Score Measurement Reported by Patients6 pain scoresStandard Deviation 0.01
Secondary

Quality of Recovery (QoR) Score

Score of QoR-15 survey to determine recovery status. The questionnaire is a 15 item questionnaire and each question has a score possible from 0-10. It has two parts. Part 1 includes questions from 1-10. the scale on this question ranges from 0=none of the time ( poor) to 10=all the time ( excellent). The 2nd part include questions from 11-15 where the scale goes from 10 to 0, where 10=none of the time ( excellent) and 0=all the time (poor). The total score is obtained by adding the scores of all the 15 questions. The total score is 0 (poor\_ to 150 (excellent).

Time frame: one week, measurements are obtained at 24 hours, 48 hours, and one week

ArmMeasureGroupValue (MEDIAN)Dispersion
ACB + iPACKQuality of Recovery (QoR) ScorePostoperative Day 1113 score on a scaleStandard Deviation 0.66
ACB + iPACKQuality of Recovery (QoR) ScorePostoperative Day 2118 score on a scaleStandard Deviation 0.37
ACB + iPACKQuality of Recovery (QoR) ScorePostoperative Day 7131 score on a scaleStandard Deviation 0.11
ACB w/o iPACKQuality of Recovery (QoR) ScorePostoperative Day 1114 score on a scaleStandard Deviation 0.66
ACB w/o iPACKQuality of Recovery (QoR) ScorePostoperative Day 2123 score on a scaleStandard Deviation 0.37
ACB w/o iPACKQuality of Recovery (QoR) ScorePostoperative Day 7126 score on a scaleStandard Deviation 0.11

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026